| Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. | |
| | |
MedLine Citation:
|
PMID: 20173157 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The purpose of this study was to compare FDG PET/CT and contrast-enhanced 64-MDCT of the chest, abdomen, and pelvis in the detection of tumor recurrence in patients with colorectal cancer and an elevated level of carcinoembryonic antigen (CEA). MATERIALS AND METHODS: A retrospective analysis included 50 patients (31 men, 19 women; mean age, 61 years; range, 28-89 years) with 55 clinical events of elevated or increasing CEA level who underwent FDG PET/CT and MDCT for suspected tumor recurrence. RESULTS: Recurrent or metastatic disease was found in 36 of 55 events (65.5%) of elevated CEA. Fifty-four of 61 tumor sites suspected as tumor recurrence with any imaging technique were found to be local recurrence or metastatic colorectal cancer at final analysis. The other seven sites were one separate malignant tumor (small lymphocytic lymphoma) and six benign lesions. Diagnosis was based on histopathologic findings (n = 27) or clinical and imaging findings (n = 35) during a median follow-up period of 12 months (range, 6-31 months). One site of tumor recurrence was missed prospectively at both MDCT and PET/CT. On an event-based analysis, the sensitivity of PET/CT and MDCT was 97.3% and 70.3% (p = 0.002); the specificity of both techniques was 94.4% (p = 1.0). In a tumor site-based analysis, the sensitivities of PET/CT and MDCT were 98.1% and 66.7% (p < 0.0001), and the specificities were 75% and 62.5% (p = 0.56). Tumors correctly identified with PET/CT and missed with MDCT were local recurrence in the presacral space (n = 5), metastatic subcentimeter lymph nodes (n = 4), peritoneal deposits (n = 3), and recurrences at the periphery of radiofrequency ablated metastatic lesions of the liver (n = 2) and in the abdominal wall (n = 1), liver (n = 1), and uterine cervix (n = 1). CONCLUSION: FDG PET/CT has higher sensitivity than MDCT in the identification of sites of recurrent and metastatic disease in patients with colorectal cancer and an elevated CEA level. The two techniques appear to have similar specificity. |
| | |
Authors:
|
Ur Metser; John You; Sean McSweeney; Marc Freeman; Aaron Hendler |
Related Documents
:
|
6863667 - Clinical value of ultrasonography for the management of non-hodgkin lymphoma patients a... 10429697 - Ovarian cancer: comparison of observer performance for four methods of interpreting ct ... 19149687 - Oncologic imaging end-points for the assessment of therapy response. 18647907 - The role of imaging in the diagnosis, staging, and management of testicular cancer. 3336717 - Splenic lymphoma: ferrite-enhanced mr imaging in rats. 3665297 - Hepatobiliary imaging and the use of intravenous morphine. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: AJR. American journal of roentgenology Volume: 194 ISSN: 1546-3141 ISO Abbreviation: AJR Am J Roentgenol Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-02-22 Completed Date: 2010-03-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7708173 Medline TA: AJR Am J Roentgenol Country: United States |
Other Details:
|
Languages: eng Pagination: 766-71 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medical Imaging, Princess Margaret Hospital, University Health Network, 610 University Ave., Ste. 3-960, Toronto, ON, M5G 2M9 Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Carcinoembryonic Antigen / blood Colorectal Neoplasms / pathology, radiography*, radionuclide imaging* Contrast Media Female Fluorodeoxyglucose F18 / diagnostic use* Humans Male Middle Aged Neoplasm Metastasis / radiography, radionuclide imaging Neoplasm Recurrence, Local / radiography*, radionuclide imaging* Radiographic Image Interpretation, Computer-Assisted Radiography, Abdominal Radiography, Thoracic Radiopharmaceuticals / diagnostic use* Sensitivity and Specificity Tomography, Emission-Computed / methods* Tomography, X-Ray Computed / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Carcinoembryonic Antigen; 0/Contrast Media; 0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluation of 188Re-DTPA-Deoxyglucose as a Potential Cancer Radiopharmaceutical.
Next Document: CT Characteristics of Lung Nodules Present at Diagnosis of Extrapulmonary Malignancy in Children.